|
Real-time Estimate
Cboe Europe
17:34:25 19/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 534.50 SEK | -0.37% |
|
+1.04% | -2.91% |
Company Valuation: MedCap AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,997 | 8,899 | 8,278 | 8,034 | - | - |
| Change | - | 78.07% | -6.99% | -2.94% | - | - |
| Enterprise Value (EV) 1 | 4,997 | 9,176 | 8,359 | 8,119 | 7,886 | 7,633 |
| Change | - | 83.61% | -8.9% | -2.86% | -2.88% | -3.2% |
| P/E | 29.1x | 42.9x | - | 32.4x | 27.2x | 24x |
| PBR | - | 6.95x | - | 4.7x | 4x | 3.43x |
| PEG | - | 2.1x | - | - | 1.4x | 1.8x |
| Capitalization / Revenue | - | 4.93x | 3.93x | 3.35x | 2.99x | 2.74x |
| EV / Revenue | - | 5.08x | 3.97x | 3.39x | 2.93x | 2.61x |
| EV / EBITDA | - | 23.7x | 18.3x | 14.7x | 12.5x | 11x |
| EV / EBIT | - | 33.7x | 27.6x | 22x | 18.1x | 16x |
| EV / FCF | - | 28.8x | 26.4x | 44.2x | 22.2x | 18x |
| FCF Yield | - | 3.47% | 3.79% | 2.26% | 4.5% | 5.55% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 11.6 | 14 | - | 16.58 | 19.7 | 22.37 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1,807 | 2,108 | 2,398 | 2,687 | 2,928 |
| EBITDA 1 | - | 387.7 | 456.3 | 551 | 631 | 693.5 |
| EBIT 1 | - | 272.3 | 302.9 | 369 | 436 | 478.5 |
| Net income 1 | 172.2 | 207.4 | 219.8 | 255.5 | 317 | 354 |
| Net Debt 1 | - | 276.5 | 81.3 | 85 | -148.5 | -401 |
| Reference price 2 | 337.50 | 601.00 | 549.00 | 536.50 | 536.50 | 536.50 |
| Nbr of stocks (in thousands) | 14,807 | 14,807 | 15,078 | 14,976 | - | - |
| Announcement Date | 31/01/24 | 31/01/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.39x | 14.74x | - | 811M | |
| 21.54x | 5.89x | 12.69x | 2.02% | 175B | |
| 13.63x | 3.36x | - | 2.6% | 147B | |
| 15.37x | 7.13x | - | 1.61% | 96.43B | |
| 17.93x | 6.36x | 11.5x | 4.79% | 85.28B | |
| 23.12x | 11.54x | 20.62x | 0.91% | 77.39B | |
| 21.29x | 11.22x | 18.33x | 4.43% | 72.31B | |
| 12.32x | 4.76x | - | 2.12% | 45.21B | |
| 11.03x | 1.63x | 5.06x | 1.34% | 44.24B | |
| Average | 17.03x | 6.14x | 13.82x | 2.48% | 82.7B | |
| Weighted average by Cap. | 17.71x | 6.38x | 13.97x | 2.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCAP Stock
- Valuation MedCap AB
Select your edition
All financial news and data tailored to specific country editions
